Paclitaxel News and Research

RSS
Paclitaxel is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Paclitaxel is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called Taxol.

The Paclitaxel compound is extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). Check for active clinical trials or closed clinical trials using this agent.
IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

Atezolizumab plus carboplatin: A winning combination for metastatic triple-negative breast cancer

Atezolizumab plus carboplatin: A winning combination for metastatic triple-negative breast cancer

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery

Trastuzumab deruxtecan offers added benefit for patients with HER2-low breast cancer

Trastuzumab deruxtecan offers added benefit for patients with HER2-low breast cancer

New study challenges long-held belief about how chemotherapy works

New study challenges long-held belief about how chemotherapy works

Study finds link between industry payments to oncologists and non-recommended cancer treatments

Study finds link between industry payments to oncologists and non-recommended cancer treatments

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%

Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%

Nano-based cancer therapies may be less effective in younger patients, finds study

Nano-based cancer therapies may be less effective in younger patients, finds study

Intensity-modulated radiation therapy reduces radiation exposure to heart and lungs in NSCLC patients

Intensity-modulated radiation therapy reduces radiation exposure to heart and lungs in NSCLC patients

Optilume BPH Catheter System offers a safe and effective treatment for benign prostatic hyperplasia

Optilume BPH Catheter System offers a safe and effective treatment for benign prostatic hyperplasia

ECOG-ACRIN launches new trial to evaluate nilotinib and paclitaxel for advanced cancers

ECOG-ACRIN launches new trial to evaluate nilotinib and paclitaxel for advanced cancers

The potential prognostic role of AhRR and PPP1R3C expression in serous ovarian cancer

The potential prognostic role of AhRR and PPP1R3C expression in serous ovarian cancer

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

Breast cancer patients experience more severe CIPN symptoms with paclitaxel

Breast cancer patients experience more severe CIPN symptoms with paclitaxel

New understanding of chemotherapeutic resistance in recurring ovarian cancer

New understanding of chemotherapeutic resistance in recurring ovarian cancer

Spinal cord stimulation may help reduce chronic pain in people undergoing active cancer treatment

Spinal cord stimulation may help reduce chronic pain in people undergoing active cancer treatment

Novel gel offers hope for patients with glioblastoma

Novel gel offers hope for patients with glioblastoma

New funding to accelerate development of potential anti-cancer compound into the clinic

New funding to accelerate development of potential anti-cancer compound into the clinic

Microglia may be the culprit behind concentration and memory problems after chemotherapy

Microglia may be the culprit behind concentration and memory problems after chemotherapy